http://orcid.org/0000-0001-5344-7824
Citations (99)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Riham M Hamadouk, Esra D Albashair, Fatimah M Mohammed & Bashir A Yousef. (2022) The Practice of the Community Pharmacists in Managing Potential Drug-Drug Interactions: A Simulated Patient Visits. Integrated Pharmacy Research and Practice 11, pages 71-84.
Read now
Read now
Ruifeng Liang, Wenjing Ge, Bingjie Li, Weifeng Cui, Xiaofan Ma, Yuying Pan & Gengsheng Li. (2022) Evodiamine decreased the systemic exposure of pravastatin in non-alcoholic steatohepatitis rats due to the up-regulation of hepatic OATPs. Pharmaceutical Biology 60:1, pages 359-373.
Read now
Read now
Isabella Damiani, Alberto Corsini & Stefano Bellosta. (2020) Potential statin drug interactions in elderly patients: a review. Expert Opinion on Drug Metabolism & Toxicology 16:12, pages 1133-1145.
Read now
Read now
Claudio Ponticelli, Lorenzo Arnaboldi, Gabriella Moroni & Alberto Corsini. (2020) Treatment of dyslipidemia in kidney transplantation. Expert Opinion on Drug Safety 19:3, pages 257-267.
Read now
Read now
Lingya Qiao, Shibo Wang, Qiang Jia, Ji Bian, Yimu Fan & Xiaolin Xu. (2019) Clinical efficacy and safety of statin treatment after carotid artery stenting. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 3110-3115.
Read now
Read now
Ricardo Lorenzoni, Leticia Malgarim Cordenonsi, Samuel Davies, Michelli Barcelos Antonow, Aline Scheinder Medina Diedrich, Cayane Genro Santos, Graciela Schneider Vitalis, Gabriela Garrastazu, Francesca Buttini, Fabio Sonvico, Patrícia Gomes & Renata Platcheck Raffin. (2019) Lipid-core nanocapsules are an alternative to the pulmonary delivery and to increase the stability of statins . Journal of Microencapsulation 36:4, pages 317-326.
Read now
Read now
Ramón Cacabelos, Natalia Cacabelos & Juan C. Carril. (2019) The role of pharmacogenomics in adverse drug reactions. Expert Review of Clinical Pharmacology 12:5, pages 407-442.
Read now
Read now
Articles from other publishers (92)
Ni-hong Pang, Ren-ai Xu, Lian-guo Chen, Zhe Chen, Guo-xin Hu & Bo-wen Zhang. (2024) Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes. Toxicology in Vitro 95, pages 105739.
Crossref
Crossref
Fan Wu, Mingyu Cui, Siwen Wang, Chao Yu, Weihong Yin, Jiao Li & Xueying Yan. (2023) Effect of Berberine on Pharmacokinetics and Pharmacodynamics of Atorvastatin in Hyperlipidemia Rats. Xenobiotica, pages 1-27.
Crossref
Crossref
Joseph A Moore, Andrew D Schreiner, Jingwen Zhang, Patrick Mauldin, William P Moran & David G Koch. (2023) Chronic liver disease is not associated with statin prescription in a primary care cohort. Journal of Investigative Medicine 71:8, pages 830-837.
Crossref
Crossref
Izzat Zulhilmi Abd Rahman, Nur Syahidah Nor Hisam, Amilia Aminuddin, Adila A. Hamid, Jaya Kumar & Azizah Ugusman. (2023) Evaluating the Potential of Plukenetia volubilis Linneo (Sacha Inchi) in Alleviating Cardiovascular Disease Risk Factors: A Mini Review. Pharmaceuticals 16:11, pages 1588.
Crossref
Crossref
Guoqing Liu, Liqiang Tan, Xiaona Zhao, Minghui Wang, Zejin Zhang, Jing Zhang, Honggang Gao, Meifang Liu & Wei Qin. (2023) Anti-atherosclerosis mechanisms associated with regulation of non-coding RNAs by active monomers of traditional Chinese medicine. Frontiers in Pharmacology 14.
Crossref
Crossref
Chang-Jiang Deng, Ju Yan, Ying-Ying Zheng, Ting-Ting Wu, Ying Pan, Xian-Geng Hou, Si-Fan Wang, Subinur Sirajidin, Mikereyi Aimaitijiang & Xiang Xie. (2023) Effectiveness of lipid-lowering therapy on mortality and major adverse cardiovascular event outcomes in patients undergoing percutaneous coronary intervention: a network meta-analysis of randomised controlled trials. BMJ Open 13:11, pages e070827.
Crossref
Crossref
Raikhan Y. Tuleutayeva, Assem R. Makhatova, Saule O. Rakhyzhanova, Lashyn K. Zhazykbayeva & Dana K. Kozhakhmetova. (2023) Candidate Genes for Prediction of Efficacy and Safety of Statin Therapy in the Kazakh Population. Twin Research and Human Genetics, pages 1-7.
Crossref
Crossref
Jingyan Li, Ruixue Liao, Shijia Zhang, Huimin Weng, Yuanzhi Liu, Tianyi Tao, Fengxu Yu, Guang Li & Jianming Wu. (2023) Promising remedies for cardiovascular disease: Natural polyphenol ellagic acid and its metabolite urolithins. Phytomedicine 116, pages 154867.
Crossref
Crossref
Wen-Qian Yu, Xiao-Lei Wang, Hong-Hai Ji, Miao Miao, Bai-Hui Zhang, Hua Li, Zi-Yi Zhang, Chen-Feng Ji & Shou-Dong Guo. (2023) CM3-SII polysaccharide obtained from Cordyceps militaris ameliorates hyperlipidemia in heterozygous LDLR-deficient hamsters by modulating gut microbiota and NPC1L1 and PPARα levels. International Journal of Biological Macromolecules 239, pages 124293.
Crossref
Crossref
Avishay Elis. (2023) Current and future options in cholesterol lowering treatments. European Journal of Internal Medicine 112, pages 1-5.
Crossref
Crossref
Huajun Wang, Shiyi Liu, Chenjie Zhou & Ye Fu. (2023) Fatal hepatic failure following atorvastatin treatment: A case report. Medicine 102:19, pages e33743.
Crossref
Crossref
Anna E Engell, Lise Bathum, John S Andersen, Wade Thompson, Bent S Lind, Henrik L Jørgensen & Jørgen Nexøe. (2023) Factors associated with statin discontinuation near end of life in a Danish primary health care cohort. Family Practice 40:2, pages 300-307.
Crossref
Crossref
Fernanda Riós, Aurora Quintero, Javier Piloni, Raquel Cariño & Abigail Reyes. (2023) Compuestos bioactivos de canela y su efecto en la disminución del síndrome metabólico: revisión sistemática. Archivos Latinoamericanos de Nutrición 73:1, pages 74-85.
Crossref
Crossref
Min Liu, Wei Shi, Yefang Huang, Yeke Wu & Keming Wu. (2023) Intestinal flora: A new target for traditional Chinese medicine to improve lipid metabolism disorders. Frontiers in Pharmacology 14.
Crossref
Crossref
Leo Tsui, Peiying Ye, Shiling Xu, Yuan Lin, Bin Chen, Sy-Ping Chen & Ruoh-Yi Cheng. (2023) Adverse drug reactions of statin therapy in China from 1989 to 2019: a national database analysis. European Journal of Hospital Pharmacy 30:e1, pages e82-e89.
Crossref
Crossref
Erica Gianazza, Maura Brioschi, Ada Iezzi, Giuseppe Paglia & Cristina Banfi. (2023) Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges. International Journal of Molecular Sciences 24:4, pages 3291.
Crossref
Crossref
Massimiliano Ruscica, Nicola Ferri, Maciej Banach, Cesare R Sirtori & Alberto Corsini. (2022) Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications. Cardiovascular Research 118:17, pages 3288-3304.
Crossref
Crossref
Xiao Bai, Si-Qi Ding, Xue-Ping Zhang, Ming-Hao Han & Dong-Qiu Dai. (2023) Exposure to Commonly Used Drugs and the Risk of Gastric Cancer: An Umbrella Review of Meta-Analyses. Cancers 15:2, pages 372.
Crossref
Crossref
Weirui Lei, Jiwen Hu, Yaqian Xie, Can Liu & Xuekun Chen. (2023) Mathematical modelling of the effects of statins on the growth of necrotic core in atherosclerotic plaque. Mathematical Modelling of Natural Phenomena 18, pages 11.
Crossref
Crossref
Keyang Zhu, Xiaoming Bao, Yingchao Wang, Ting Lu & Ling Zhang. (2023) Human induced pluripotent stem cell (hiPSC)-derived cardiomyocyte modelling of cardiovascular diseases for natural compound discovery. Biomedicine & Pharmacotherapy 157, pages 113970.
Crossref
Crossref
Nihar R. Desai, Michael Farbaniec & Dean G. Karalis. (2022) Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease. Clinical Cardiology 46:1, pages 13-21.
Crossref
Crossref
Jieyu Xiang, Ling Zhou, Yuanlong Xie, Yufan Zhu, Lingfei Xiao, Yan Chen, Wei Zhou, Danyang Chen, Min Wang, Lin Cai & Liang Guo. (2022) Mesh-like electrospun membrane loaded with atorvastatin facilitates cutaneous wound healing by promoting the paracrine function of mesenchymal stem cells. Stem Cell Research & Therapy 13:1.
Crossref
Crossref
Yuanlong Sun, Na Hu, Gaofeng Chen, Yanjie Wang, Yiyang Hu, Maojun Ge & Yu Zhao. (2022) Efficacy and safety of Qushi Huayu granule for hyperlipidemia: study protocol for a randomized, double-blind, placebo-controlled trial. Trials 23:1.
Crossref
Crossref
Yung-Chang Lu, Ting-Kuo Chang, Tzu-Chiao Lin, Shu-Ting Yeh, Hsu-Wei Fang, Chun-Hsiung Huang & Chang-Hung Huang. (2022) The potential role of herbal extract Wedelolactone for treating particle-induced osteolysis: an in vivo study. Journal of Orthopaedic Surgery and Research 17:1.
Crossref
Crossref
A. Muñoz-Blanco, R. Gómez-Huelgas & J.F. Gómez-Cerezo. (2022) Statin-associated muscle symptoms: Myth or reality?. Revista Clínica Española (English Edition) 222:10, pages 602-611.
Crossref
Crossref
A. Muñoz-Blanco, R. Gómez-Huelgas & J.F. Gómez-Cerezo. (2022) Sintomatología muscular asociada a estatinas: ¿mito o realidad?. Revista Clínica Española 222:10, pages 602-611.
Crossref
Crossref
Felicia Liana Andronie-Cioară, Anamaria Jurcău, Maria Carolina Jurcău, Delia Carmen Nistor-Cseppentö & Aurel Simion. (2022) Cholesterol Management in Neurology: Time for Revised Strategies?. Journal of Personalized Medicine 12:12, pages 1981.
Crossref
Crossref
Lanjing Wang, Lijun Liu, Yanhong Zhao, Min Chu & Jijun Teng. (2022) Lipoprotein(a) and residual vascular risk in statin-treated patients with first acute ischemic stroke: A prospective cohort study. Frontiers in Neurology 13.
Crossref
Crossref
Donald G. LamprechtJrJr, Joseph J. Saseen & Paul B. Shaw. (2022) Clinical conundrums involving statin drug-drug interactions. Progress in Cardiovascular Diseases 75, pages 83-89.
Crossref
Crossref
Viorel I. Suica, Elena Uyy, Luminita Ivan, Raluca M. Boteanu, Aurel Cerveanu-Hogas, Rune Hansen & Felicia Antohe. (2022) Cardiac Alarmins as Residual Risk Markers of Atherosclerosis under Hypolipidemic Therapy. International Journal of Molecular Sciences 23:19, pages 11174.
Crossref
Crossref
Caiping Zhang, Debiao Xiang, Qian Zhao, Susu Jiang, Chuyao Wang, Huixian Yang, Ying Huang, Yulin Yuan, Xuanyou Liu, Zhixin Huang, Yaling Zeng, Hongyan Wen, Shiyin Long, Hong Hao, Qinhui Tuo, Zhenguo Liu & Duanfang Liao. (2022) Curcumin nicotinate decreases serum LDL cholesterol through LDL receptor-mediated mechanism. European Journal of Pharmacology 931, pages 175195.
Crossref
Crossref
Mei Zhao, Chuan-Fen Liu, Yu-Fei Feng & Hong Chen. (2022) Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study. Frontiers in Pharmacology 13.
Crossref
Crossref
Litong Qi, Jiyan Chen, Xiaodong Li, Xiaoyong Qi, Chunhua Ding, Xiaoping Chen, Xiang Gu, Wenliang Xiao, Shuiping Zhao, Yugang Dong, Mingqi Zheng, Kai Huang, Liangqiu Tang, Xiaomei Guo, Fang Wang, Guosheng Fu, Junxia Li & Yong Huo. (2022) Efficacy and safety of hybutimibe in combination with atorvastatin for treatment of hypercholesteremia among patients with atherosclerotic cardiovascular disease risk equivalent: A multicenter, randomized, double-blinded phase III study. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Jiao Wang, Shuo Zhang, Meng Xing, Seokgyeong Hong, Liu Liu, Xiao-Jie Ding, Xiao-ying Sun, Ying Luo, Chun-xiao Wang, Miao Zhang, Bin Li & Xin Li. (2022) Current evidence on the role of lipid lowering drugs in the treatment of psoriasis. Frontiers in Medicine 9.
Crossref
Crossref
Yuan Xu, Jian Lu, Yuanqing Guo, Yuanjin Zhang, Jie Liu, Shengbo Huang, Yanfang Zhang, Liangcai Gao & Xin Wang. (2022) Hypercholesterolemia reduces the expression and function of hepatic drug metabolizing enzymes and transporters in rats. Toxicology Letters 364, pages 1-11.
Crossref
Crossref
Nianxin Yang, Yatian Yang, Zenghong Huang & Hong-Wu Chen. (2022) Deregulation of Cholesterol Homeostasis by a Nuclear Hormone Receptor Crosstalk in Advanced Prostate Cancer. Cancers 14:13, pages 3110.
Crossref
Crossref
Jiao Tian, Bin Feng & Zhen Tian. (2022) The Effect of Curcumin on Lipid Profile and Glycemic Status of Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-13.
Crossref
Crossref
Jiaqi Xu, Jinling Zhang, Yumei Sang, Yaning Wei, Xingyue Chen, Yuanxin Wang & Hongkun Xue. (2022) Polysaccharides from Medicine and Food Homology Materials: A Review on Their Extraction, Purification, Structure, and Biological Activities. Molecules 27:10, pages 3215.
Crossref
Crossref
Carolina Dagli-Hernandez, Jéssica Bassani Borges, Elisangela da Silva Rodrigues Marçal, Renata Caroline Costa de Freitas, Augusto Akira Mori, Rodrigo Marques Gonçalves, Andre Arpad Faludi, Victor Fernandes de Oliveira, Glaucio Monteiro Ferreira, Gisele Medeiros Bastos, Yitian Zhou, Volker M. Lauschke, Alvaro Cerda, Mario Hiroyuki Hirata & Rosario Dominguez Crespo Hirata. (2022) Genetic Variant ABCC1 rs45511401 Is Associated with Increased Response to Statins in Patients with Familial Hypercholesterolemia. Pharmaceutics 14:5, pages 944.
Crossref
Crossref
Yuan Li, Miao Miao, Fan Yin, Nuo Shen, Wen-Qian Yu & Shou-Dong Guo. (2022)
The polysaccharide–peptide complex from mushroom
Cordyceps militaris
ameliorates atherosclerosis by modulating the lncRNA–miRNA–mRNA axis
. Food & Function 13:6, pages 3185-3197.
Crossref
Crossref
Lingqing Ding, Congqin Chen, Yongkuan Yang, Jie Fang, Longxing Cao & Yige Liu. (2022) Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System. Cardiovascular Therapeutics 2022, pages 1-9.
Crossref
Crossref
Yusuke Kobayashi, Takashi Takeda, Haruko Kunitomi, Fumiko Chiwaki, Masayuki Komatsu, Shimpei Nagai, Yuya Nogami, Kosuke Tsuji, Kenta Masuda, Hideaki Ogiwara, Hiroki Sasaki, Kouji Banno & Daisuke Aoki. (2022) Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer. Pharmaceuticals 15:2, pages 124.
Crossref
Crossref
Ana V. Pejčić, Slobodan M. Janković & Goran Davidović. (2022) Risk factors for potential drug-drug interactions of statins in patients with acute coronary syndrome. Brazilian Journal of Pharmaceutical Sciences 58.
Crossref
Crossref
E.J. Palacio-Portilla, J. Roquer, S. Amaro, J.F. Arenillas, O. Ayo-Martín, M. Castellanos, M.M. Freijo, B. Fuentes, A. García-Pastor, M. Gomis, M. Gómez-Choco, E. López-Cancio, P. Martínez-Sánchez, A. Morales, M. Rodríguez-Yáñez, T. Segura, J. Serena, J. Vivancos-Mora & M.A. de Leciñana. (2022) Dyslipidemias and stroke prevention: Recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology. Neurología (English Edition) 37:1, pages 61-72.
Crossref
Crossref
E.J. Palacio-Portilla, J. Roquer, S. Amaro, J.F. Arenillas, O. Ayo-Martín, M. Castellanos, M.M. Freijo, B. Fuentes, A. García-Pastor, M. Gomis, M. Gómez-Choco, E. López-Cancio, P. Martínez-Sánchez, A. Morales, M. Rodríguez-Yáñez, T. Segura, J. Serena, J. Vivancos-Mora & M.A. de Leciñana. (2022) Dislipidemias y prevención del ictus: recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología. Neurología 37:1, pages 61-72.
Crossref
Crossref
Mingyu Cui, Fengmei Zhu, Yifeng Yin, Yue Sui, Xueying Yan & Tingting Chen. (2021) Influence of Gegenqinlian Decoction on Pharmacokinetics and Pharmacodynamics of Atorvastatin Calcium in Hyperlipidemic Rats. European Journal of Drug Metabolism and Pharmacokinetics 47:1, pages 117-126.
Crossref
Crossref
Selvin Noé Palacios-Rápalo, Luis Adrián De Jesús-González, Carlos Daniel Cordero-Rivera, Carlos Noe Farfan-Morales, Juan Fidel Osuna-Ramos, Gustavo Martínez-Mier, Judith Quistián-Galván, Armando Muñoz-Pérez, Víctor Bernal-Dolores, Rosa María del Ángel & José Manuel Reyes-Ruiz. (2021) Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry. Frontiers in Immunology 12.
Crossref
Crossref
Mariana Silva, Biane Philadelpho, Johnnie Santos, Victória Souza, Caio Souza, Victória Santiago, Jaff Silva, Carolina Souza, Francine Azeredo, Marcelo Castilho, Eduardo Cilli & Ederlan Ferreira. (2021) IAF, QGF, and QDF Peptides Exhibit Cholesterol-Lowering Activity through a Statin-like HMG-CoA Reductase Regulation Mechanism: In Silico and In Vitro Approach. International Journal of Molecular Sciences 22:20, pages 11067.
Crossref
Crossref
Meng-Wan Zhang, Xiao-Hui Wang, Jing Shi & Jian-Guang Yu. (2021) Sinomenine in Cardio-Cerebrovascular Diseases: Potential Therapeutic Effects and Pharmacological Evidences. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Alexander D Hilt, Beerend P Hierck, Joep Eijkenduijn, Fons J Wesselius, Armagan Albayrak, Marijke Melles, Martin J Schalij & Roderick W C Scherptong. (2021) Development of a patient-oriented Hololens application to illustrate the function of medication after myocardial infarction. European Heart Journal - Digital Health 2:3, pages 511-520.
Crossref
Crossref
Brian Lu, Laura Sun, Manuel Seraydarian, Thomas J. Hoffmann, Marisa W. Medina, Neil Risch, Carlos Iribarren, Ronald M. Krauss & Akinyemi Oni‐Orisan. (2021)
Effect of
SLCO1B1 T521C
on Statin‐Related Myotoxicity With Use of Lovastatin and Atorvastatin
. Clinical Pharmacology & Therapeutics 110:3, pages 733-740.
Crossref
Crossref
Emilie Borne, Nicolas Meyer, Odile Blanchard, Martial Lombard, Thomas Vogel, Pierre‐Olivier Lang & Bruno Michel. (2021) Statin (mis)use in older people: A cross‐sectional study using French health insurance databases. Pharmacoepidemiology and Drug Safety 30:8, pages 1084-1090.
Crossref
Crossref
So Young Kim, Chang Ho Lee, Chanyang Min, Dae Myoung Yoo & Hyo Geun Choi. (2021) Association between statin medication and hearing impairment in a national health screening cohort. Scientific Reports 11:1.
Crossref
Crossref
Songyu Liu, Yu Long, Shuang Yu, Dingkun Zhang, Qiyue Yang, Zhimin Ci, Mingquan Cui, Yulu Zhang, Jinyan Wan, Dan Li, Ai Shi, Nan Li, Ming Yang & Junzhi Lin. (2021) Borneol in cardio-cerebrovascular diseases: Pharmacological actions, mechanisms, and therapeutics. Pharmacological Research 169, pages 105627.
Crossref
Crossref
Dongting Yang, Wentao Lyu, Ziyi Hu, Jiting Gao, Zhiyao Zheng, Weijun Wang, Jenni Firrman & Daxi Ren. (2021) Probiotic Effects of Lactobacillus fermentum ZJUIDS06 and Lactobacillus plantarum ZY08 on Hypercholesteremic Golden Hamsters. Frontiers in Nutrition 8.
Crossref
Crossref
Mohamad Kareem Marrache & Don C. Rockey. (2021) Statins for treatment of chronic liver disease. Current Opinion in Gastroenterology 37:3, pages 200-207.
Crossref
Crossref
Maryam Mahjoubin-Tehran, Yong Teng, Amin Jalili, Seyed Hamid Aghaee-Bakhtiari, Alexander M. Markin & Amirhossein Sahebkar. (2021) Decoy Technology as a Promising Therapeutic Tool for Atherosclerosis. International Journal of Molecular Sciences 22:9, pages 4420.
Crossref
Crossref
Lindsey C. Yourman, Irena S. Cenzer, W. John Boscardin, Brian T. Nguyen, Alexander K. Smith, Mara A. Schonberg, Nancy L. Schoenborn, Eric W. Widera, Ariela Orkaby, Annette Rodriguez & Sei J. Lee. (2021) Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years. JAMA Internal Medicine 181:2, pages 179.
Crossref
Crossref
MikhailA Filippov, OlgaG Tatarnikova, NataliaV Pozdnyakova & VasilyV Vorobyov. (2021) Inflammation/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophylls. Neural Regeneration Research 16:2, pages 223.
Crossref
Crossref
Bhuvana Sunil & Ambika P. Ashraf. 2021. Endocrine Conditions in Pediatrics. Endocrine Conditions in Pediatrics
339
347
.
C. S. Pitchumoni & Mitesh A. Desai. 2021. Geriatric Gastroenterology. Geriatric Gastroenterology
2277
2298
.
S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova, N. N. Landyshev, Ya. G. Voronko & A. M. Lutsenko. (2020) Lipid-lowering therapy in outpatients of different ages with coronary artery disease. Cardiovascular Therapy and Prevention 19:5, pages 2654.
Crossref
Crossref
Roberta de Pádua Borges, Nathália Abi Habib Degobi & Marcello Casaccia Bertoluci. (2020) Choosing statins: a review to guide clinical practice. Archives of Endocrinology and Metabolism.
Crossref
Crossref
Zohaib Iqbal, Jan Hoong Ho, Safwaan Adam, Michael France, Akheel Syed, Dermot Neely, Alan Rees, Rani Khatib, Jaimini Cegla, Christopher Byrne, Nadeem Qureshi, Nigel Capps, Gordon Ferns, Jules Payne, Jonathan Schofield, Kirsty Nicholson, Dev Datta, Alison Pottle, Julian Halcox, Andrew Krentz, Paul Durrington & Handrean Soran. (2020) Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK. Atherosclerosis 313, pages 126-136.
Crossref
Crossref
Chaker Ben Salem, Dhouha Sahnoun, Raoudha Slim, Fatma Ben Fradj & Chedia Aouani. (2020) Atorvastatin and sildenafil interaction-induced rhabdomyolysis. Annals of Pharmacotherapy 54:10, pages 1047-1048.
Crossref
Crossref
Ailin Elyasi, Iryna Voloshyna, Saba Ahmed, Lora J. Kasselman, Jennifer Behbodikhah, Joshua De Leon & Allison B. Reiss. (2020) The role of interferon-γ in cardiovascular disease: an update. Inflammation Research 69:10, pages 975-988.
Crossref
Crossref
Emily R. Finch, Monique A. Payton, David A. Jenkins, Xiangjun Cai, Lie Li, Seth E. Karol, Mary V. Relling & Laura J. Janke. (2020) Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated mice. Haematologica 106:8, pages 2095-2101.
Crossref
Crossref
Vincenzo Russo, Roberta Bottino, Andreina Carbone, Anna Rago, Andrea Antonio Papa, Paolo Golino & Gerardo Nigro. (2020) COVID-19 and Heart: From Clinical Features to Pharmacological Implications. Journal of Clinical Medicine 9:6, pages 1944.
Crossref
Crossref
Qiwen Wang, Jie Shen, Enqi Mo, Haotian Zhang, Jianwei Wang, Xiurong Hu, Jun Zhou, Hongzhen Bai & Guping Tang. (2020)
A versatile ultrafine and super-absorptive H
+
-modified montmorillonite: application for metabolic syndrome intervention and gastric mucosal protection
. Biomaterials Science 8:12, pages 3370-3380.
Crossref
Crossref
Gerald F. Watts, Samuel S. Gidding, Pedro Mata, Jing Pang, David R. Sullivan, Shizuya Yamashita, Frederick J. Raal, Raul D. Santos & Kausik K. Ray. (2020) Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care. Nature Reviews Cardiology 17:6, pages 360-377.
Crossref
Crossref
Caterina Palleria, Roberta Roberti, Luigi Francesco Iannone, Martina Tallarico, Maria Antonietta Barbieri, Ada Vero, Antonia Manti, Giovambattista De Sarro, Edoardo Spina & Emilio Russo. (2019) Clinically relevant drug interactions between statins and antidepressants. Journal of Clinical Pharmacy and Therapeutics 45:2, pages 227-239.
Crossref
Crossref
Kyeong Ju Lee, Kyung Rim Kim, Jae Min Seong, Seung Wan Ryu, Hyun Yoon Lee, Sekyoung Cho, Yeji Cheong, Ki Nam Nam & Yu Jeung Lee. (2020) Evaluation of Potential Drug-Drug Interactions in Patients Taking HMG CoA-reductase Inhibitors. Korean Journal of Clinical Pharmacy 30:1, pages 31-35.
Crossref
Crossref
Zhen Zhou, Loai Albarqouni, Andrea J. Curtis, Monique Breslin & Mark Nelson. (2020) The Safety and Tolerability of Statin Therapy in Primary Prevention in Older Adults: A Systematic Review and Meta-analysis. Drugs & Aging 37:3, pages 175-185.
Crossref
Crossref
Meng-Hsuan Kuo, Chih-Wei Tseng, Chi-Hui Lee & Kuo-Chih Tseng. (2020) Drug-drug interactions between direct-acting antivirals and statins in the treatment of chronic hepatitis C. Tzu Chi Medical Journal 32:4, pages 331.
Crossref
Crossref
José Luis Garduño Hernández. (2020) Interacciones farmacológicas potenciales en pacientes ambulatorios en expedientes de queja médica de la CONAMED. Revista CONAMED 25:3, pages 115-122.
Crossref
Crossref
C. S. Pitchumoni & Mitesh A. Desai. 2020. Geriatric Gastroenterology. Geriatric Gastroenterology
1
23
.
Stefano Bellosta, Alberto Corsini & Nicola Ferri. 2020. Statin-Associated Muscle Symptoms. Statin-Associated Muscle Symptoms
51
61
.
Morsy, Abdel-Latif, Nair, Venugopala, Ahmed, Elsewedy & Shehata. (2019) Preparation and Evaluation of Atorvastatin-Loaded Nanoemulgel on Wound-Healing Efficacy. Pharmaceutics 11:11, pages 609.
Crossref
Crossref
Festus Kamau, Hans Strijdom, Peter Mwangi, Dee Blackhurst, Emiliana Imperial & Ruduwaan Salie. (2019) Antiretroviral drug-induced endothelial dysfunction is improved by dual PPARα/γ stimulation in obesity. Vascular Pharmacology 121, pages 106577.
Crossref
Crossref
Francielly Mourão GasparottoRhanany Alan Calloi PaloziClaudio Henrique Francisconi da SilvaKaroline Bach PauliGuilherme DonadelBruno Henrique Lopes Botelho LourençoBruna Caroline NunesFrancislaine Aparecida dos Reis LíveroLauro Mera de SouzaEmerson Luiz Botelho LourençoCândida Aparecida Leite KassuyaArquimedes Gasparotto Junior. (2019)
Antiatherosclerotic Properties of
Echinodorus grandiflorus
(Cham. & Schltdl.) Micheli: From Antioxidant and Lipid-Lowering Effects to an Anti-Inflammatory Role
. Journal of Medicinal Food 22:9, pages 919-927.
Crossref
Crossref
Benjamin Castagné, Marie Viprey, Julie Martin, Anne-Marie Schott, Michel Cucherat & Martin Soubrier. (2019) Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis. PLOS ONE 14:8, pages e0220178.
Crossref
Crossref
Masahiko Gosho. (2018) Rhabdomyolysis risk from the use of two‐drug combination of antidyslipidemic drugs with antihypertensive and antidiabetic medications: a signal detection analysis. Fundamental & Clinical Pharmacology 33:3, pages 339-346.
Crossref
Crossref
Aaron S. Devanathan, Daijha J.C. Anderson, Mackenzie L. Cottrell, Erin M. Burgunder, Ashley C. Saunders & Angela D.M. Kashuba. (2019)
Contemporary Drug–Drug Interactions in
HIV
Treatment
. Clinical Pharmacology & Therapeutics 105:6, pages 1362-1377.
Crossref
Crossref
Liang-Tsai Yeh, Chuan-Yi Tang, Shun-Fa Yang, Han-Wei Yeh, Ying-Tung Yeh, Yu-Hsun Wang, Ming-Chih Chou, Chao-Bin Yeh & Chi-Ho Chan. (2019) Association between Statin Use and Sepsis Risk in Patients with Dementia: A Retrospective Cohort Study. International Journal of Environmental Research and Public Health 16:9, pages 1626.
Crossref
Crossref
Fatemeh Vahdat Lasemi, Maryam Mahjoubin Tehran, Seyed Hamid Aghaee-Bakhtiari, Amin Jalili, Mahmoud Reza Jaafari & Amirhossein Sahebkar. (2019) Harnessing nucleic acid-based therapeutics for atherosclerotic cardiovascular disease: state of the art. Drug Discovery Today 24:5, pages 1116-1131.
Crossref
Crossref
Julien Bezin & Nicholas Moore. (2019) Pharmacoepidemiology of statins. Therapies 74:2, pages 261-269.
Crossref
Crossref
Rocío Montejano, Rosa de Miguel & José I. Bernardino. (2019) Older HIV-infected adults: complex patients—comorbidity (I). European Geriatric Medicine 10:2, pages 189-197.
Crossref
Crossref
Natalie C. WardGerald F. WattsRobert H. Eckel. (2019) Statin Toxicity. Circulation Research 124:2, pages 328-350.
Crossref
Crossref
Jie Yang, Junichi Hasegawa, Yusuke Endo, Kazuhiko Iitsuka, Miwa Yamamoto & Akiko Matsuda. (2019) Pharmacokinetic Drug Interaction Between Rosuvastatin and Tanjin in Healthy Volunteers and Rats. Yonago Acta Medica 62:1, pages 077-084.
Crossref
Crossref
Cesario F. Bianchi & Orlando Petrucci. (2019) A better treatment for saphenous vein graft disease after coronary artery bypass surgery: Might statins be the answer at the right dose to the right patient at the right time?. The Journal of Thoracic and Cardiovascular Surgery 157:1, pages 162-163.
Crossref
Crossref
Fatemeh Forouzanfar, Alexandra E. Butler, Maciej Banach, George E. Barreto & Amirhossein Sahbekar. (2018) Modulation of heat shock proteins by statins. Pharmacological Research 134, pages 134-144.
Crossref
Crossref
Stefan Weisshaar & Markus Zeitlinger. (2018) Vaccines Targeting PCSK9: A Promising Alternative to Passive Immunization with Monoclonal Antibodies in the Management of Hyperlipidaemia?. Drugs 78:8, pages 799-808.
Crossref
Crossref